Archive: 2025/11 - Page 3

IgA Nephropathy: Prognosis and Current Therapies in 2025

IgA Nephropathy is the most common cause of primary kidney inflammation. In 2025, new guidelines and targeted therapies like Nefecon are transforming prognosis-making it possible to slow or stop progression if caught early and treated aggressively.

How Donepezil Reduces Caregiver Burden in Alzheimer's Disease

Donepezil helps slow cognitive decline in Alzheimer’s patients, leading to fewer daily care tasks, improved sleep, and reduced stress for caregivers. Real-world evidence shows measurable improvements in both patient function and caregiver well-being.

How Alfacalcidol Improves Muscle Strength and Function in Older Adults

Alfacalcidol is a prescription vitamin D analog that helps older adults regain muscle strength and balance by improving how the body uses vitamin D. Studies show it reduces fall risk and improves mobility in those with deficiency.